Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Suction vs. gravity: which drainage method better protects heart bypass patients?

NCT ID NCT07814573

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

After coronary artery bypass grafting, doctors place tubes to drain fluid from around the heart. This trial compares two ways of monitoring that drainage: using gentle negative pressure (suction) or letting it drain on its own. Researchers will track fluid buildup around the heart, total drainage volume, and complications like irregular heartbeats or bleeding in 400 adults having planned bypass surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
negative-pressure drainage monitoring
What this could lead to
If negative pressure works better, it could become a standard way to drain fluid after heart bypass surgery and reduce complications like fluid around the heart.
What could go wrong
This is a single-center study of 400 people, so results may not apply everywhere. Negative pressure could also cause more bleeding or other problems, which the trial is designed to detect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing coronary artery bypass graft surgery * Age range of 18-80 * Elective operations Exclusion Criteria: * Emergency operations * Patients under 18 and over 80 years of age * Reoperations * Patients with significant preoperative pleural or pericardial effusion * Patients with known coagulopathy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Complications due to coronary artery bypass graft are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Başakşehir Çam Ve Sakura Şehir Hastanesi

    Istanbul, Istanbul, 34480, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.